# Study to Evaluate Efficacy and Safety of LIB003 in Patients on Lipid-Lowering Therapy Needing Additional LDL-C Reduction

> **NCT03549260** · PHASE2 · COMPLETED · sponsor: **LIB Therapeutics LLC** · enrollment: 81 (actual)

## Conditions studied

- LDL Cholesterol

## Interventions

- **BIOLOGICAL:** LIB003

## Key facts

- **NCT ID:** NCT03549260
- **Lead sponsor:** LIB Therapeutics LLC
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2018-05-22
- **Primary completion:** 2018-11-09
- **Final completion:** 2018-11-30
- **Target enrollment:** 81 (ACTUAL)
- **Last updated:** 2019-02-18

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03549260

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03549260, "Study to Evaluate Efficacy and Safety of LIB003 in Patients on Lipid-Lowering Therapy Needing Additional LDL-C Reduction". Retrieved via AI Analytics 2026-06-16 from https://api.ai-analytics.org/clinical/NCT03549260. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*